C6-pyridinium ceramide sensitizes SCC17B human head and neck squamous cell carcinoma cells to photodynamic therapy.

[1]  A. Bielawska,et al.  Ceramide synthase inhibitor fumonisin B1 inhibits apoptotic cell death in SCC17B human head and neck squamous carcinoma cells after Pc4 photosensitization , 2014, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[2]  A. Bielawska,et al.  Increased killing of SCCVII squamous cell carcinoma cells after the combination of Pc 4 photodynamic therapy and dasatinib is associated with enhanced caspase-3 activity and ceramide synthase 1 upregulation , 2013, International journal of oncology.

[3]  K. Kragballe,et al.  Evaluation of recurrence after photodynamic therapy with topical methylaminolaevulinate for 157 basal cell carcinomas in 90 patients. , 2012, Acta Dermato-Venereologica.

[4]  Wei Zhang,et al.  Amplification of cancer cell apoptosis in photodynamic therapy‐treated tumors by adjuvant ceramide analog LCL29 , 2011, Lasers in surgery and medicine.

[5]  Y. Hannun,et al.  Many Ceramides* , 2011, The Journal of Biological Chemistry.

[6]  John Calvin Reed,et al.  Mitochondrial Ceramide-Rich Macrodomains Functionalize Bax upon Irradiation , 2011, PloS one.

[7]  M. E. Kenney,et al.  Preliminary Clinical and Pharmacologic Investigation of Photodynamic Therapy with the Silicon Phthalocyanine Photosensitizer Pc 4 for Primary or Metastatic Cutaneous Cancers , 2011, Frontiers in Oncology.

[8]  A. Bielawska,et al.  Mitochondrially targeted ceramides preferentially promote autophagy, retard cell growth, and induce apoptosis , 2011, Journal of Lipid Research.

[9]  M. Korbelik,et al.  Enhanced Tumor Cures after Foscan Photodynamic Therapy Combined with the Ceramide Analog LCL29. Evidence from Mouse Squamous Cell Carcinomas for Sphingolipids as Biomarkers of Treatment Response , 2011, International journal of oncology.

[10]  Y. Ohsumi,et al.  PtdIns 3-Kinase Orchestrates Autophagosome Formation in Yeast , 2011, Journal of lipids.

[11]  A. Bielawska,et al.  C16-Ceramide Analog Combined with Pc 4 Photodynamic Therapy Evokes Enhanced Total Ceramide Accumulation, Promotion of DEVDase Activation in the Absence of Apoptosis, and Augmented Overall Cell Killing , 2010, Journal of lipids.

[12]  Kevin D Cooper,et al.  Silicon phthalocyanine (pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trial , 2010, Lasers in surgery and medicine.

[13]  M. Korbelik,et al.  Increased tumour dihydroceramide production after Photofrin-PDT alone and improved tumour response after the combination with the ceramide analogue LCL29. Evidence from mouse squamous cell carcinomas , 2009, British Journal of Cancer.

[14]  Claire M. Brown,et al.  Analysis of Signaling Events by Combining High-Throughput Screening Technology with Computer-Based Image Analysis , 2008, Science Signaling.

[15]  Y. Hannun,et al.  Translational aspects of sphingolipid metabolism. , 2007, Trends in molecular medicine.

[16]  A. Bielawska,et al.  Tailoring structure-function and targeting properties of ceramides by site-specific cationization. , 2006, Bioorganic & medicinal chemistry.

[17]  A. Bielawska,et al.  Potent Antitumor Activity of a Novel Cationic Pyridinium-Ceramide Alone or in Combination with Gemcitabine against Human Head and Neck Squamous Cell Carcinomas in Vitro and in Vivo , 2006, Journal of Pharmacology and Experimental Therapeutics.

[18]  Jeffrey A. Jones,et al.  Positively Charged Ceramide Is a Potent Inducer of Mitochondrial Permeabilization* , 2005, Journal of Biological Chemistry.

[19]  A. Bielawska,et al.  Inhibition of growth and telomerase activity by novel cationic ceramide analogs with high solubility in human head and neck squamous cell carcinoma cells , 2005, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[20]  M. Tainsky,et al.  De Novo Ceramide Accumulation Due to Inhibition of Its Conversion to Complex Sphingolipids in Apoptotic Photosensitized Cells* , 2004, Journal of Biological Chemistry.

[21]  Barbara W. Henderson,et al.  Choice of Oxygen-Conserving Treatment Regimen Determines the Inflammatory Response and Outcome of Photodynamic Therapy of Tumors , 2004, Cancer Research.

[22]  S. Hahn,et al.  Patterns of recurrence in patients treated with photodynamic therapy for intraperitoneal carcinomatosis and sarcomatosis. , 2004, International journal of oncology.

[23]  N. Oleinick,et al.  Dissociation of mitochondrial depolarization from cytochrome c release during apoptosis induced by photodynamic therapy , 2001, British Journal of Cancer.

[24]  N. Thornberry,et al.  Inhibition of Human Caspases by Peptide-based and Macromolecular Inhibitors* , 1998, The Journal of Biological Chemistry.

[25]  A. Merrill,et al.  Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme. , 1991, The Journal of biological chemistry.

[26]  M. Biel,et al.  Photodynamic therapy of head and neck cancers. , 2010, Methods in molecular biology.

[27]  Jean-Jacques Grob,et al.  Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. , 2004, Archives of dermatology.

[28]  L. B. Chen,et al.  Mitochondrial membrane potential in living cells. , 1988, Annual review of cell biology.